DK164149C - Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet - Google Patents

Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet

Info

Publication number
DK164149C
DK164149C DK057085A DK57085A DK164149C DK 164149 C DK164149 C DK 164149C DK 057085 A DK057085 A DK 057085A DK 57085 A DK57085 A DK 57085A DK 164149 C DK164149 C DK 164149C
Authority
DK
Denmark
Prior art keywords
preparation
preparation containing
hydroxyprogesteronacetate
substance
procedure
Prior art date
Application number
DK057085A
Other languages
Danish (da)
English (en)
Other versions
DK57085A (da
DK57085D0 (da
DK164149B (da
Inventor
Fabio Carli
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of DK57085D0 publication Critical patent/DK57085D0/da
Publication of DK57085A publication Critical patent/DK57085A/da
Publication of DK164149B publication Critical patent/DK164149B/da
Application granted granted Critical
Publication of DK164149C publication Critical patent/DK164149C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK057085A 1984-02-08 1985-02-07 Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet DK164149C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848403360A GB8403360D0 (en) 1984-02-08 1984-02-08 Pharmaceutical compositions
GB8403360 1984-02-08

Publications (4)

Publication Number Publication Date
DK57085D0 DK57085D0 (da) 1985-02-07
DK57085A DK57085A (da) 1985-08-09
DK164149B DK164149B (da) 1992-05-18
DK164149C true DK164149C (da) 1992-10-12

Family

ID=10556300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK057085A DK164149C (da) 1984-02-08 1985-02-07 Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet

Country Status (32)

Country Link
US (1) US4632828A (ko)
JP (1) JPS60181017A (ko)
KR (1) KR930009897B1 (ko)
AT (1) AT388869B (ko)
AU (1) AU577351B2 (ko)
BE (1) BE901664A (ko)
BG (1) BG60524B2 (ko)
CA (1) CA1240928A (ko)
CH (1) CH664693A5 (ko)
CZ (1) CZ277728B6 (ko)
DE (1) DE3503679A1 (ko)
DK (1) DK164149C (ko)
ES (3) ES8607984A1 (ko)
FI (1) FI84230C (ko)
FR (1) FR2559065B1 (ko)
GB (2) GB8403360D0 (ko)
GR (1) GR850312B (ko)
HK (1) HK94290A (ko)
HU (1) HU194050B (ko)
IE (1) IE58230B1 (ko)
IL (1) IL74241A (ko)
IT (1) IT1209615B (ko)
NL (1) NL192780C (ko)
NO (1) NO170568C (ko)
NZ (1) NZ211058A (ko)
PT (1) PT79933B (ko)
SE (2) SE8500553L (ko)
SG (1) SG80390G (ko)
SK (1) SK278084B6 (ko)
SU (1) SU1605926A3 (ko)
UA (1) UA6028A1 (ko)
ZA (1) ZA85943B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
GB8806367D0 (en) * 1988-03-17 1988-04-13 Erba Carlo Spa Siloxane matrices with internal non-uniform drug distribution
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
AUPS244002A0 (en) * 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
JP2005094910A (ja) * 2003-09-17 2005-04-07 Aruze Corp モータ停止制御装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
AU454482B2 (en) * 1970-11-05 1974-10-15 Alza Corporation Drug-delivery system
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
GB2067900B (en) * 1980-01-25 1983-06-22 Ddsa Pharmaceuticals Ltd Medicinal tablets
DE3006635A1 (de) * 1980-02-22 1981-08-27 Basf Ag, 6700 Ludwigshafen Verwendung von mikronisiertem vernetztem, unloeslichem polyvinylpyrrolidon zur stabilisierung von suspensionen
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
DE3125178A1 (de) * 1981-06-26 1983-01-13 Gödecke AG, 1000 Berlin Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen
DE3205399A1 (de) * 1982-02-16 1983-08-25 Bayer Ag, 5090 Leverkusen Feste, schnellfreisetzende arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
EP0084190A3 (en) * 1981-12-08 1984-11-28 Fisons Plc Medicinal composition, package and method of making the composition
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss

Also Published As

Publication number Publication date
ES539874A0 (es) 1986-06-01
SE8500553L (sv) 1985-08-09
IE850261L (en) 1985-08-08
SK278084B6 (en) 1995-12-06
FI850455L (fi) 1985-08-09
SG80390G (en) 1990-11-23
NO170568C (no) 1992-11-04
FI84230C (fi) 1991-11-11
AU3848885A (en) 1985-08-15
AU577351B2 (en) 1988-09-22
NO850477L (no) 1985-08-09
IL74241A0 (en) 1985-05-31
FI850455A0 (fi) 1985-02-04
PT79933A (en) 1985-03-01
SE8500553D0 (sv) 1985-02-06
DE3503679A1 (de) 1985-08-08
NL8500323A (nl) 1985-09-02
DK57085A (da) 1985-08-09
DK57085D0 (da) 1985-02-07
GB8503033D0 (en) 1985-03-06
PT79933B (en) 1987-02-02
BG60524B2 (bg) 1995-07-28
IE58230B1 (en) 1993-08-11
CH664693A5 (de) 1988-03-31
GB2153677B (en) 1988-04-13
GB2153677A (en) 1985-08-29
AT388869B (de) 1989-09-11
FR2559065A1 (fr) 1985-08-09
NZ211058A (en) 1988-09-29
ES550614A0 (es) 1987-02-16
ES8703278A1 (es) 1987-02-16
HUT37890A (en) 1986-03-28
DK164149B (da) 1992-05-18
ZA85943B (en) 1985-10-30
IT8519385A0 (it) 1985-02-05
DE3503679C2 (ko) 1992-05-07
HU194050B (en) 1988-01-28
BE901664A (fr) 1985-08-06
NO170568B (no) 1992-07-27
ATA31685A (de) 1989-02-15
SU1605926A3 (ru) 1990-11-07
IT1209615B (it) 1989-08-30
FI84230B (fi) 1991-07-31
NL192780C (nl) 1998-02-03
GB8403360D0 (en) 1984-03-14
ES550613A0 (es) 1987-02-16
HK94290A (en) 1990-11-23
US4632828A (en) 1986-12-30
NL192780B (nl) 1997-10-01
IL74241A (en) 1988-12-30
ES8703277A1 (es) 1987-02-16
CA1240928A (en) 1988-08-23
SE462547B (sv) 1990-07-16
KR850005858A (ko) 1985-09-26
JPH0415769B2 (ko) 1992-03-19
FR2559065B1 (fr) 1988-09-09
CS78485A3 (en) 1992-11-18
KR930009897B1 (ko) 1993-10-13
CZ277728B6 (en) 1993-04-14
UA6028A1 (uk) 1994-12-29
ES8607984A1 (es) 1986-06-01
JPS60181017A (ja) 1985-09-14
GR850312B (ko) 1985-06-05

Similar Documents

Publication Publication Date Title
DK510384A (da) Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK407588A (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
DK236285A (da) Anordning til langsom frigivelse af et medikament i en droevtyggers mave
DK386287D0 (da) Anvendelse af et hydrofobt stof til fremstilling af et enterisk praeparat til behandling af fedme samt enteriske praeparater
DK64183D0 (da) Farmaceutisk praeparat samt fremgangsmade til fremstilling deraf
DK615988D0 (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK164149C (da) Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet
DK537685D0 (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK284585A (da) 1,4-dihydropyrinderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse
DK645788D0 (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK106685D0 (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK337489D0 (da) Spiro-azabicyclisk forbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse samt fremgangsmaade til fremstilling af en saadan forbindelse
DK95489D0 (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK459589D0 (da) Tetrahydronaphthalen- og indanderivater og farmaceutiske midler indeholdende disse samt anvendelse af forbindelserne til fremstilling af et laegemiddel
DK203581A (da) Hidtil ukendte substituerede 2(3h)-benzothiazoloner fremgangsmaader til deres fremstilling deres anvendelse til fremstilling af laegemidler samt laegemidler der indeholder disse forbindelser
DK157036C (da) Endo-deoxyribonuklease a samt fremgangsmaade til fremstilling af samme
DK476583D0 (da) Vandig oploesning af et jernkompleks samt fremgangsmade til fremstilling af en farmaceutisk oploesning indeholdende dette kompleks
DK150482A (da) Fremgangsmaade til fremstilling af formlegemer af polylaurinlaktam samt de derved fremstillede formlegemer
DK434685D0 (da) Fremgangsmaade til fremstilling af hidtil ukendte hydroxythioalkener samt de herved fremstillede forbindelser
DK561787D0 (da) Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel

Legal Events

Date Code Title Description
PUP Patent expired